Table 3 Underlying comorbidities among MIS-C patients at admission
Variable n = 20 | No. (%) |  | No. (%) |
|---|---|---|---|
Inflammatory disorders | 2 (10.0) | Chronic Kidney Disorders | 0 (0.0) |
Hypertension / Chronic Cardiac Disease | 1 (5.0) | Chronic Neurological Disorders | 0 (0.0) |
Asthma / Chronic Pulmonary Disease | 1 (5.0) | Congenital Immune suppression | 1 (5.0) |
Malignant Disorders | 0 (0.0) | Diabetes/ Endocrine Disorders | 0 (0.0) |
History of contact with confirmed COVID-19 Infection (COVID-19 PCR positive) | 10 (50.0) | Chronic Liver Disorders | 0 (0.0) |
History of contact with unconfirmed COVID-19 Infection | 10 (50.0) | Haematological Disorders | 0 (0.0) |